1-3 of 3
Richard Houghton
Close
Sort by
Journal Articles

Cytokine release in patients with CLL treated with obinutuzumab and possible relationship with infusion-related reactions

Clinical Trials & Observations
Ciara L. Freeman, Franck Morschhauser, Laurie Sehn, Mark Dixon, Richard Houghton, Thierry Lamy, Günter Fingerle-Rowson, Elisabeth Wassner-Fritsch, John G. Gribben, Michael Hallek, Gilles Salles, Guillaume Cartron
Journal: Blood
Blood (2015) 126 (24): 2646–2649.
https://doi.org/10.1182/blood-2015-09-670802
Published: 2015
Journal Articles

Pattern of Cytokine Release in Patients with Chronic Lymphocytic Leukemia Treated with Obinutuzumab and Possible Relationship with Development of Infusion Related Reactions (IRR)

Ciara Louise Freeman, MRCP, MD, Franck Morschhauser, MD PhD, Laurie H. Sehn, MDMPH, Mark Dixon, Richard Houghton, Thierry Lamy, MD, Gunter Fingerle-Rowson, MD PhD, Elisabeth Wassner-Fritsch, Michael Hallek, MD, Gilles Salles, MD PhD, Guillaume Cartron, MD
Journal: Blood
Blood (2014) 124 (21): 4674.
https://doi.org/10.1182/blood.V124.21.4674.4674
Published: 2014
Journal Articles

Risk Factors Associated with the Development of Infusion-Related Reactions in Patients with Chronic Lymphocytic Leukaemia Treated with Anti-CD20 Monoclonal Antibodies: Analysis of the CLL11 Study Dataset

Ciara Louise Freeman, MRCP, MD, Mark Dixon, Richard Houghton, Kathryn Humphrey, Gunter Fingerle-Rowson, MD PhD, Karl-Anton Kreuzer, MD, Anja Engelke, MD, Michael Hallek, MD, Valentin Goede, MD
Journal: Blood
Blood (2014) 124 (21): 3339.
https://doi.org/10.1182/blood.V124.21.3339.3339
Published: 2014